Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-07

Clinical Trial Update: Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating a prednisone, vinblastine, doxorubicin, and gemcitabine regimen in elderly patients with advanced Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxorubicin (doxorubicin)
  • Gemcitabine (Gemcitabine)
  • PREDNISONE (Prednisone)
  • Vinblastine (vinblastine)

Snippet

Sponsor: University of Cologne | Conditions: Hodgkin's Disease | Phase 1, Phase 2 | Status: COMPLETED